파마코스텍

비상장계속사업자

Pharmacostech.Co.,Ltd

김재원

Investment Review Report

Auto-filled from disclosures & public data + AI-drafted analysis. Edit, then export to PDF/DOCX.

Editor

1.Deal Terms

2.Valuation / Exit Assumptions

Exit Scenarios100M KRW

3.Fund Eligibility

Fund mandate eligibility — no data, enter manually

Enter fund mandate requirements and applicability (Y/N) to include a table in the report.

4.Capital Changes

Not in DART — enter capital-raise history manually

Enter capital changes such as founding capital and paid-in increases.

5.Stock Options

Enter manually

Enter stock option grant history.

6.Investment Highlights

AI draft — editable

Click 'Generate AI draft' to populate data-grounded investment highlights.

7.Investment Risks

AI draft — editable

Risks are populated after 'Generate AI draft'.

8.Market Analysis

AI draft — editable

9.Business Analysis

AI draft — editable

10.Conclusion (Investment Opinion)

AI draft — editable

11.P&L Projection

Analyst estimates, manual entry (100M KRW). Generates a trend chart & table.

Enter projected revenue / op. profit / net income (100M KRW) by year to add a trend chart and table.
Preview— the document below is saved as PDF/DOCX

Investment Review Report

파마코스텍

Business Reg. No. 3038127585 · CEO 김재원

I.Investment Overview

Target파마코스텍 (3038127585)
Investment
Post-deal stake
ValuationPre — / Post —

II.Investment Highlights

No investment highlights written yet.

III.Investment Risks

No risks written yet.

IV.Company Profile

회사명파마코스텍
영문명Pharmacostech.Co.,Ltd
대표자김재원
사업자등록번호3038127585
법인등록번호1545110018683
설립일2000.10.04

V.Financial Summary

Per DART disclosure · in 억/만원 (KRW)

Financial trend (100M KRW)

매출액100M KRW232.82021349.52022339.420232342024377.52025
영업이익100M KRW15.6202157.6202265.22023-5202435.32025
순이익100M KRW16.9202154202277.4202372024312025
Item20252024202320222021
자산총계609.5억원570.6억원522.7억원404.7억원351.2억원
부채총계127.1억원121.1억원76.8억원35.4억원33.9억원
자본총계482.4억원449.4억원445.9억원369.3억원317.3억원
매출액377.5억원234억원339.4억원349.5억원232.8억원
영업이익35.3억원-5억원65.2억원57.6억원15.6억원
순이익31억원7억원77.4억원54억원16.9억원

VI.Financial Ratios

FY2025 basis

9.34%

영업이익률

8.22%

순이익률

5.09%

ROA

6.43%

ROE

26.35%

부채비율

79.15%

자기자본비율

VII.Valuation & Exit Plan

Exit valuation
Holding period5y
Enter exit assumptions (investment, stake, exit valuation, period) to see MOIC·IRR.

This report compiles disclosure & public data and AI-drafts some sections as a research aid. It is not investment advice; the user bears final responsibility for facts and investment decisions.

파마코스텍 투심보고서 | Alpha Lenz